We ask that the media do not contact researchers while this critical work is underway, and instead use the press office contact details (below) for press enquiries.
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
Further announcements and updates on this study will appear on this page in due course.
Press Mailing list
If you would like to receive updates about this trial, please email firstname.lastname@example.org and you will be added to our mailing list. This list is for press contacts only.
The University Hospitals Bristol and Weston NHS Foundation Trust’s (UHBW) Data Privacy Notice describes how we collect and use your personal data submitted to us online, by email, on paper or face-to-face, in accordance with the General Data Protection Regulation (GDPR) and associated data protection legislation.
Contact Us (Press only)
This information is for Press enquiries only. If you would like to find out more about participating in the trial, please click on the following link to find a study site near you.
Please read the press releases above before contacting us as your question may be answered there. For further enquiries, please contact the UHBW Press Office, via email@example.com or 0117 342 3629 / 3718. We will try to respond to your message (if appropriate) as soon as we can, however we are unable to respond to all messages and responses may be delayed due to the nature of the current situation.